Article Information
History
- September 3, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ritthideach Yorsaeng,
- Preeyaporn Vichaiwattana,
- Sirapa Klinfueng,
- Lakkhana Wongsrisang,
- Natthinee Sudhinaraset,
- Sompong Vongpunsawad* and
- Yong Poovorawan
- ↵*Address for correspondence:
Sompong Vongpunsawad, Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, 1873 Rama 4 Road, Pathumwan, Bangkok 10330, Thailand; email: sompong.vo{at}chula.ac.th; phone: +66 2 256 4909; fax: +66 2 256 4929.
Posted September 03, 2021.
Immune response elicited from heterologous SARS-CoV-2 vaccination: Sinovac (CoronaVac) followed by AstraZeneca (Vaxzevria)
